常溫體外循環機市場：依應用、器官類型、最終用戶、灌注類型、組件、地區分類

預計到 2026 年，常溫灌注機市場價值將達到 20.5 億美元，到 2033 年將達到 65.7 億美元，2026 年至 2033 年的複合年成長率為 18.11%。

全球常溫機械灌注市場代表著器官保存技術的變革性進步，它透過在儲存和運輸過程中將器官維持在生理溫度下，從根本上革新了移植醫學。與傳統的冷藏方法不同，常溫機械灌注系統能夠在體溫（37 度C）下保存器官，同時提供持續的含氧血液供應，顯著延長器官的存活時間，並改善移植效果。這項創新技術解決了器官移植領域的關鍵挑戰，包括器官短缺、保存品質和長期儲存等問題，從而擴大了捐贈者來源，並有助於提高受者的生存率。

該市場涵蓋先進的灌注設備、專用灌注液、監測系統以及為全球醫療機構提供支援的完善服務網路。隨著末期器官疾病的增加，全球對器官移植的需求日益成長，常溫機械灌注技術已成為彌合醫療系統中器官供應與患者需求之間差距的關鍵解決方案。該技術已被證實能夠評估移植前器官功能、減輕缺血再灌流傷害並實現體外器官修復，使其成為現代移植通訊協定的重要組成部分，推動了市場顯著成長，並吸引了醫療設備製造商和醫療服務提供者的大量投資。

市場動態

全球常溫灌注機市場正經歷強勁成長，主要得益於多種有利因素。其中一個關鍵促進因素是全球可移植器官的嚴重短缺，這導致對能夠最大限度利用器官並延長器官保存時間的技術需求迫切。肝硬化、腎衰竭和心臟病等慢性疾病的增加，顯著擴大了需要器官移植的患者數量。此外，全球人口老化也加劇了器官需求的成長，並促使捐贈者標準更加廣泛。灌注系統的技術進步，例如自動化監測、即時器官評估功能以及灌注液生物相容性的提高，正在改善臨床療效，並促進其在移植中心的應用。

越來越多的臨床證據表明，與冷凍保存方法相比，器官移植具有更優的器官保存效果、更低的原發性功能障礙率和更高的長期移植存活率，這推動了醫生對移植的信心，並促使醫療機構採用移植技術。

然而，市場限制因素包括灌注設備的大量資本投入、持續的營運成本（包括專用灌注液和技術專長）以及因地區而異的複雜設備核准監管流程。某些醫療保健系統對保險覆蓋範圍的限制也構成了廣泛應用的經濟障礙，而對專業培訓和技術支援的需求則給小規模移植中心帶來了實施方面的挑戰。儘管存在這些限制因素，但隨著應用範圍從肝臟和腎臟保存擴展到心臟、肺臟和胰腺灌注；由於保存技術的進步，擴大標準供體器官的接受度不斷提高；以及新興市場醫療基礎設施的建設（移植項目正在迅速發展），市場仍蘊藏著巨大的機遇。

本報告的主要特點

• 本報告對全球常溫灌注機市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和復合年成長率。
• 它還重點介紹了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
• 它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的關鍵見解。
• 全球常溫灌注機市場的主要企業會根據以下參數進行概況介紹，例如公司概況、產品系列、主要亮點、財務表現和策略。
• 本報告提供的見解將使負責人和公司經營團隊能夠就未來的產品發布、產品更新、市場擴張和行銷策略做出明智的決策。
• 《全球常溫灌注機市場》報告針對該產業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員可以透過各種策略矩陣更輕鬆地做出決策，這些矩陣用於分析全球常溫灌注機市場。

目錄

第1章 分析目標與先決條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進要素
• 抑制因素
• 機會
• 影響分析
• 重大進展
• 監管情景
• 產品發布/核准
• PEST分析
• 波特五力分析
• 企業合併情景
• 產業趨勢

4. 全球常暖體外循環機市場依應用領域分類（2021-2033 年）

• 器官保存
• 器官修復
• 器官移植

5. 全球常溫體外循環機市場（依器官類型分類）（2021-2033 年）

• 腎
• 肝
• 心
• 肺
• 胰臟

6. 全球常溫灌注機市場（依最終用戶分類）（2021-2033 年）

• 醫院、手術中心
• 器官移植中心
• 研究所
• 器官獲取組織

7. 全球常溫灌注機市場（依灌注類型分類）（2021-2033 年）

• 低溫機械灌注
• 室溫機械灌注

8. 全球常溫灌注機市場（依組件分類）（2021-2033 年）

• 耗材（試管、溶液組、過濾器）
• 設備（灌注設備、感測器）
• 軟體（監控和數據分析系統）

第9章 全球室溫機械灌注市場：按地區分類（2021-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
• 非洲
  • 南非
  • 北非
  • 中非

第10章 競爭格局

• TransMedics Group Inc
• Organ Recovery Systems
• XVIVO Perfusion AB
• OrganOx Limited
• Getinge（Paragonix Technologies）
• Bridge to Life Ltd
• Waters Medical Systems
• Preservation Solutions Inc
• Institut Georges Lopez SA
• EBERS Medical Technology SL
• Shenzhen Lifotronic Technology Co Ltd
• Genus Medical Technologies LLC
• Terumo Corporation
• Medtronic plc
• LivaNova Plc

第11章 分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map (COM)

第12章 參考文獻與分析方法

• 參考
• 分析方法
• 關於 Coherent Market Insights

Normothermic Machine Perfusion Market is estimated to be valued at USD 2.05 Bn in 2026 and is expected to reach USD 6.57 Bn by 2033, expanding at a compound annual growth rate (CAGR) of 18.11% from 2026 to 2033.

The global normothermic machine perfusion market represents a transformative advancement in organ preservation technology, fundamentally revolutionizing transplantation medicine by maintaining organs at physiological temperatures during storage and transport. Unlike traditional cold storage methods, normothermic machine perfusion systems preserve organs at body temperature (37°C) while providing continuous oxygenated blood flow, significantly extending organ viability and improving transplantation outcomes. This innovative technology addresses critical challenges in organ transplantation, including organ shortage, preservation quality, and extended storage times, thereby expanding the donor pool and enhancing recipient survival rates.

The market encompasses sophisticated perfusion devices, specialized perfusion solutions, monitoring systems, and comprehensive service networks that support healthcare institutions worldwide. As healthcare systems globally face increasing demand for organ transplants amid growing prevalence of end-stage organ diseases, normothermic machine perfusion technology emerges as a crucial solution bridging the gap between organ availability and patient needs. The technology's proven ability to assess organ functionality before transplantation, reduce ischemia-reperfusion injury, and enable ex-vivo organ repair positions it as an indispensable component of modern transplantation protocols, driving substantial market growth and attracting significant investment from medical device manufacturers and healthcare providers.

Market Dynamics

The global normothermic machine perfusion market experiences robust growth driven by multiple compelling factors, with the primary driver being the critical shortage of transplantable organs worldwide, creating urgent demand for technologies that maximize organ utilization and extend preservation periods. Increasing prevalence of chronic diseases such as liver cirrhosis, kidney failure, and heart disease significantly amplifies the patient population requiring organ transplants, while aging demographics globally contribute to both increased organ demand and expanded donor criteria acceptance. Technological advancements in perfusion systems, including automated monitoring, real-time organ assessment capabilities, and improved biocompatibility of perfusion solutions, enhance clinical outcomes and drive adoption among transplant centers.

Growing clinical evidence demonstrating superior organ preservation, reduced primary non-function rates, and improved long-term graft survival compared to cold storage methods strengthens physician confidence and institutional adoption.

However, market restraints include substantial capital investment requirements for perfusion equipment, ongoing operational costs including specialized perfusion fluids and technical expertise, and complex regulatory pathways for device approval across different regions. Limited reimbursement coverage in certain healthcare systems creates financial barriers for widespread adoption, while the need for specialized training and technical support infrastructure poses implementation challenges for smaller transplant centers. Despite these constraints, significant opportunities emerge from expanding applications beyond liver and kidney preservation to include heart, lung, and pancreas perfusion, growing acceptance of extended criteria donor organs through improved preservation techniques, and increasing healthcare infrastructure development in emerging markets where transplantation programs are expanding rapidly.

Key Features of the Study

• This report provides in-depth analysis of the global normothermic machine perfusion market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global normothermic machine perfusion market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include TransMedics Group Inc, Organ Recovery Systems, XVIVO Perfusion AB, OrganOx Limited, Getinge (Paragonix Technologies), Bridge to Life Ltd, Waters Medical Systems, Preservation Solutions Inc, Institut Georges Lopez SA, EBERS Medical Technology SL, Shenzhen Lifotronic Technology Co Ltd, Genus Medical Technologies LLC, Terumo Corporation, Medtronic plc, and LivaNova Plc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global normothermic machine perfusion market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global normothermic machine perfusion market

Market Segmentation

• Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Organ Preservation
  • Organ Reconditioning
  • Organ Transplantation
• Organ Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas
• End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals and Surgical Centers
  • Organ Transplantation Centers
  • Research Laboratories
  • Organ Procurement Organizations
• Type of Perfusion Insights (Revenue, USD Bn, 2021 - 2033)
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
• Component Insights (Revenue, USD Bn, 2021 - 2033)
  • Consumables (Tubing, Solution Kits, Filters)
  • Devices (Perfusion Machines, Sensors)
  • Software (Monitoring and Data Analysis Systems)
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • TransMedics Group Inc
  • Organ Recovery Systems
  • XVIVO Perfusion AB
  • OrganOx Limited
  • Getinge (Paragonix Technologies)
  • Bridge to Life Ltd
  • Waters Medical Systems
  • Preservation Solutions Inc
  • Institut Georges Lopez SA
  • EBERS Medical Technology SL
  • Shenzhen Lifotronic Technology Co Ltd
  • Genus Medical Technologies LLC
  • Terumo Corporation
  • Medtronic plc
  • LivaNova Plc

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Normothermic Machine Perfusion Market, By Application
  • Global Normothermic Machine Perfusion Market, By Organ Type
  • Global Normothermic Machine Perfusion Market, By End User
  • Global Normothermic Machine Perfusion Market, By Type of Perfusion
  • Global Normothermic Machine Perfusion Market, By Component
  • Global Normothermic Machine Perfusion Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Normothermic Machine Perfusion Market, By Application, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Organ Preservation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Organ Reconditioning
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Organ Transplantation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Normothermic Machine Perfusion Market, By Organ Type, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Kidney
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Liver
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Heart
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Lung
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Pancreas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Normothermic Machine Perfusion Market, By End User, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals and Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Organ Transplantation Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Research Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Organ Procurement Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Normothermic Machine Perfusion Market, By Type of Perfusion, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hypothermic Machine Perfusion
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Normothermic Machine Perfusion
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Normothermic Machine Perfusion Market, By Component, 2021-2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Consumables (Tubing, Solution Kits, Filters)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Devices (Perfusion Machines, Sensors)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
• Software (Monitoring and Data Analysis Systems)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

9. Global Normothermic Machine Perfusion Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Type of Perfusion, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Component, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• TransMedics Group Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Organ Recovery Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• XVIVO Perfusion AB
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• OrganOx Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Getinge (Paragonix Technologies)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bridge to Life Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Waters Medical Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Preservation Solutions Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Institut Georges Lopez SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EBERS Medical Technology SL
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Shenzhen Lifotronic Technology Co Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Genus Medical Technologies LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LivaNova Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us